| Target Validation Information | |||||
|---|---|---|---|---|---|
| Target ID | T11822 | ||||
| Target Name | Retinoic acid receptor | ||||
| Target Type | Successful |
||||
| Drug Potency against Target | Vitamin A | Drug Info | IC50 = 5 nM | [553252] | |
| Action against Disease Model | Isotretinoin | EC50 on differentiating N1E-115 cells: 16000nM | [552841] | Drug Info | |
| Adapalene | Normal h uMan keratinocytes transglutaminase 1 expression IC50: 2.5 nM | [553294] | Drug Info | ||
| References | |||||
| Ref 553252 | Didehydroretinoic acid: retinoid receptor-mediated transcriptional activation and binding properties. Biochem Pharmacol. 1997 Apr 4;53(7):1049-53. | ||||
| Ref 552841 | Effect of culture age on the susceptibility of differentiating neuroblastoma cells to retinoid cytotoxicity. Biotechnol Bioeng. 1996 Jun 5;50(5):580-6. | ||||
| Ref 553294 | Pharmacology of adapalene. Br J Dermatol. 1998 Oct;139 Suppl 52:3-7. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

